Verastem | VSTM - Assets

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $131.7M in Assets for its fiscal quarter ending in March of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
AstraZeneca USD 114.07B 382M Dec/2025
Curis USD 29.23M 10.09M Jun/2025
Cytokinetics USD 1.44B 210.92M Sep/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
Laboratory Of America USD 18.26B 201.7M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
TG Therapeutics USD 1.03B 322.41M Sep/2025
Verastem USD 131.7M 30.16M Mar/2025